Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Immunogenicity of the Plasmodium falciparum Pf332-DBL domain in combination with different adjuvants.

Immunogenicity of the Plasmodium falciparum Pf332-DBL domain in combination with different adjuvants. Vaccine. 2010 Jul 12; 28(31):4977-83.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.